Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 26% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 8% |
Insufficient scRNA-seq data for expression of KLF15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 99% | 5769.64 | 224 / 226 | 97% | 84.11 | 394 / 406 |
prostate | 96% | 2267.84 | 235 / 245 | 100% | 45.08 | 501 / 502 |
brain | 94% | 1781.86 | 2496 / 2642 | 99% | 83.52 | 697 / 705 |
kidney | 93% | 2040.49 | 83 / 89 | 80% | 21.85 | 723 / 901 |
pancreas | 100% | 3241.02 | 327 / 328 | 48% | 6.47 | 85 / 178 |
ovary | 100% | 5490.93 | 180 / 180 | 47% | 6.54 | 202 / 430 |
skin | 55% | 847.62 | 1001 / 1809 | 77% | 14.77 | 364 / 472 |
lung | 81% | 2396.89 | 468 / 578 | 33% | 5.08 | 385 / 1155 |
thymus | 73% | 1377.61 | 479 / 653 | 40% | 5.82 | 241 / 605 |
bladder | 86% | 3277.71 | 18 / 21 | 26% | 3.45 | 131 / 504 |
stomach | 97% | 2923.43 | 350 / 359 | 13% | 1.73 | 36 / 286 |
uterus | 89% | 2339.52 | 151 / 170 | 17% | 2.59 | 78 / 459 |
adrenal gland | 53% | 522.94 | 136 / 258 | 49% | 8.28 | 113 / 230 |
eye | 0% | 0 | 0 / 0 | 99% | 22.72 | 79 / 80 |
muscle | 98% | 4683.85 | 784 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 5406.18 | 1300 / 1335 | 0% | 0 | 0 / 0 |
breast | 86% | 3115.40 | 397 / 459 | 10% | 1.11 | 110 / 1118 |
adipose | 94% | 3592.64 | 1136 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 75% | 3186.11 | 1086 / 1445 | 14% | 1.46 | 25 / 183 |
heart | 86% | 2226.92 | 741 / 861 | 0% | 0 | 0 / 0 |
intestine | 73% | 1655.51 | 708 / 966 | 11% | 1.38 | 59 / 527 |
spleen | 24% | 243.87 | 59 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 3.37 | 5 / 45 |
peripheral blood | 0% | 3.62 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901653 | Biological process | cellular response to peptide |
GO_0046326 | Biological process | positive regulation of glucose import |
GO_0072112 | Biological process | podocyte differentiation |
GO_0014898 | Biological process | cardiac muscle hypertrophy in response to stress |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010001 | Biological process | glial cell differentiation |
GO_0032868 | Biological process | response to insulin |
GO_0001678 | Biological process | intracellular glucose homeostasis |
GO_2000757 | Biological process | negative regulation of peptidyl-lysine acetylation |
GO_0030111 | Biological process | regulation of Wnt signaling pathway |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KLF15 |
Protein name | Krueppel-like factor 15 (Kidney-enriched krueppel-like factor) |
Synonyms | KKLF |
Description | FUNCTION: Transcriptional regulator that binds to the GA element of the CLCNKA promoter. Binds to the KCNIP2 promoter and regulates KCNIP2 circadian expression in the heart (By similarity). Is a repressor of CCN2 expression, involved in the control of cardiac fibrosis. It is also involved in the control of cardiac hypertrophy acting through the inhibition of MEF2A and GATA4 (By similarity). Involved in podocyte differentiation (By similarity). Inhibits MYOCD activity. Is a negative regulator of TP53 acetylation. Inhibits NF-kappa-B activation through repression of EP300-dependent RELA acetylation. . |
Accessions | Q9UIH9 ENST00000296233.4 |